EDGAR Filing Documents for 0000950170-24-041803

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000950170-24-041803

Filing Date

2024-04-04

Accepted

2024-04-04 16:10:06

Documents

Period of Report

2024-04-02

Document Format Files

Seq	Description	Document	Type	Size
1	4	ownership.html	4
1	4	ownership.xml	4	5797
	Complete submission text file	0000950170-24-041803.txt		7180

Mailing Address 80 GUEST STREET BOSTON MA 01235

Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864

Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110

Business Address

Kilroy Conor (Reporting) CIK: 0001808510 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 24823240